Jonathan Braun
30Patents
7h-index
27Co-inventors
69Inventor score
Filing activity: Sep 14, 1994 → Apr 27, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6033864A | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens | Emerging Cross-Sectional Technologies | 95 | Expired |
| US6309643A | IBD-associated microbial antigens and methods of using same | Chemistry; Metallurgy | 89 | Expired |
| US5691151A | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca | Emerging Cross-Sectional Technologies | 40 | Expired |
| US7138237B1 | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5691135A | Immunoglobulin superantigen binding to gp 120 from HIV | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5738847A | Anti-VH3-15 reagents and methods for their use | Chemistry; Metallurgy | 8 | Expired |
| US7183065B2 | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens | Emerging Cross-Sectional Technologies | 8 | Expired |
| US8318906B2 | EMP2 antibodies and their therapeutic uses | Chemistry; Metallurgy | 5 | Active |
| US6320037A | IBD-associated microbial nucleic acid molecules | Chemistry; Metallurgy | 4 | Expired |
| US10028983B2 | Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life | Emerging Cross-Sectional Technologies | 3 | Active |
| US7993867B2 | Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen | Emerging Cross-Sectional Technologies | 3 | Active |
| US7993866B2 | Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen | Emerging Cross-Sectional Technologies | 3 | Active |
| US7993865B2 | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen | Emerging Cross-Sectional Technologies | 3 | Active |
| US8445200B2 | Genotoxicity as a biomarker for inflammation | Chemistry; Metallurgy | 3 | Active |
| US7557194B2 | Antibody materials for an IBD-associated polypeptide | Chemistry; Metallurgy | 2 | Expired |
| US6821739B2 | Methods of diagnosing and treating Crohn's disease using Pseudomonas antigens | Physics | 2 | Expired |
| US6759530B2 | IBD-associated microbial nucleic acid molecules | Chemistry; Metallurgy | 2 | Expired |
| US6537768B1 | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9624304B2 | Antibodies which bind to epithelial membrane protein 2 (EMP2) | Chemistry; Metallurgy | 0 | Active |
| US9464135B2 | Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR) | Human Necessities | 0 | Active |
| US8779104B2 | EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereof | Chemistry; Metallurgy | 0 | Active |
| US9011857B2 | Methods of treating cancer by administering EMP2 antibodies | Chemistry; Metallurgy | 0 | Active |
| US10385395B2 | Diagnostic tools for response to 6-thiopurine therapy | Physics | 0 | Active |
| US8940491B2 | Genotoxicity as a biomarker for inflammation | Chemistry; Metallurgy | 0 | Active |
| US8785602B2 | EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or symptoms thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.